Clinical Trial Update: CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat [Phase 4]

View source ↗

Summary

A Phase 4 comparative effectiveness trial comparing allopurinol vs febuxostat in gout patients, including those with chronic kidney disease; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Gout

Drugs mentioned

• Allopurinol (Allopurinol)
• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Gout, Chronic Kidney Diseases | Phase 4 | Status: COMPLETED | Results posted: 2022-01-11